RNU7-187P

Across TCGA pan-cancer cohorts, RNU7-187P RNA is linked to patient survival in 7 of 34 cancer types, making it the most broadly survival-associated RNU7-187P data layer.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where higher RNU7-187P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RNU7-187P expression acts as an unfavorable survival marker.

BLCA, UCEC, and KIRC are the cancer types where RNU7-187P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BLCA	DFS	Tertile	All	0.089	0.628	<.001	90	view →
UCEC	DFS	Tertile	All	0.249	0.840	<.001	90	view →
KIRC	OS	Tertile	All	0.151	0.883	<.001	72	view →
BRCA	OS	Tertile	II,III,IV	0.855	0.958	.004	60	view →
LUSC	OS	Tertile	All	0.073	0.762	<.001	36	view →
ACC	OS	Tertile	All	0.147	0.685	.018	18	view →
HNSC	DFS	Tertile	All	0.421	0.712	.001	15	view →

Pink = unfavorable, green = favorable. Showing the 7 strongest of 7 lineages.

RNU7-187P–BLCA (DFS)

Open the BLCA breakdown →